Myth Check: Is Laser the First-Line Fix for Melasma? What the Mechanism Actually Says

Ask around any aesthetic corridor in Beverly Hills and you will hear a familiar promise: a few laser sessions can erase melasma the way they erase sun spots. The claim is understandable, because lasers are genuinely excellent at destroying discrete pigment. But melasma is not a discrete pigment problem. It is a chronic, hormonally and light-sensitive condition in which the pigment-producing cells themselves are overactive, and that distinction changes everything about how energy-based devices should, and should not, be used.

Why melasma is not a sun spot. A solar lentigo is essentially a localized deposit of excess melanin with relatively normal melanocytes around it. Vaporize or shatter that deposit and the skin usually clears. Melasma, by contrast, involves hyperfunctional melanocytes, often with pigment sitting in both the epidermis and the dermis, plus increased vascularity and low-grade inflammation in the surrounding tissue. The melanin you see is the output, not the disease. Any treatment that removes pigment without calming the machinery that produces it invites recurrence, and any treatment that inflames the skin can push that machinery into overdrive. This is the mechanism behind the most common melasma complication seen after aggressive laser work: rebound hyperpigmentation, where the treated area returns darker than it started, sometimes within weeks. For an independent overview, see Melasma and pigmentation: diagnosis and treatment.

The heat problem. Melanocytes respond to injury signals. Thermal damage, ultraviolet light, visible light, friction, and hormonal shifts can all upregulate melanin production through overlapping inflammatory pathways. High-fluence lasers and ablative resurfacing deliver exactly the kind of thermal insult that melasma-prone skin interprets as a threat. This is why intense pulsed light and traditional Q-switched lasers at standard sun-spot settings have such an inconsistent track record in melasma, particularly in patients with Fitzpatrick skin types III to VI, who make up a large share of Southern California patients.

Where lasers legitimately fit. None of this means lasers are useless for melasma. It means they are adjuncts, used at deliberately gentle settings, after the condition is medically stabilized. The most studied approach is low-fluence 1064 nm Q-switched or picosecond Nd:YAG, often called laser toning. The 1064 nm wavelength penetrates past the epidermis with relatively modest melanin absorption, and at low fluences the goal is subcellular fragmentation of melanosomes rather than destruction of the melanocyte, which limits the inflammatory signal. Picosecond pulses may offer a further advantage because ultrashort pulse durations rely more on photoacoustic effects than heat, shrinking the thermal footprint. Non-ablative fractional lasers at conservative densities have supporting evidence as well, partly because the microscopic channels they create can improve penetration of topical lightening agents. Even so, published response rates are partial, maintenance is expected, and relapse after sun exposure is the rule rather than the exception.

What first-line actually looks like. Dermatology guidelines consistently place topicals and photoprotection ahead of devices. That typically means a tinted mineral sunscreen containing iron oxides, because melasma responds to visible light, not just UV, and standard clear sunscreens do not block visible wavelengths. It means hydroquinone-based combination creams or alternatives such as azelaic acid, tranexamic acid, and cysteamine, prescribed and monitored by a clinician. Oral tranexamic acid, used off-label in appropriately screened patients, has become a common addition for stubborn cases because it interferes with the plasmin-mediated signaling between keratinocytes, blood vessels, and melanocytes that helps drive the condition. Lasers enter the conversation when this foundation is in place and pigment persists, not before.

Questions worth asking at a consultation. First, will the provider perform a Wood's lamp or dermoscopic assessment to gauge pigment depth, since dermal-predominant melasma responds poorly to almost everything and expectations should be set accordingly. Second, what settings will be used, and is there a plan for a test spot in a discreet area before treating the full face. Third, what is the pretreatment protocol; many clinicians prime the skin with topical lightening agents for 2 to 4 weeks before any energy delivery to quiet melanocyte activity. Fourth, what is the maintenance plan, because a series of 4 to 8 gentle sessions without ongoing topicals and rigorous daily photoprotection is a plan for relapse.

The bottom line. Melasma is a chronic condition to be managed, not a spot to be removed. Lasers, used conservatively and in the right sequence, can meaningfully improve it. Used as a first-line, high-energy quick fix, they can make it worse in ways that take months to undo. Any consultation that skips the topical foundation, promises permanent clearance, or treats melasma with the same settings used for sun spots deserves a second opinion. In a market as device-rich as Beverly Hills, the most valuable thing a patient can bring to the chair is a clear understanding that with melasma, restraint is the treatment.

Related reading: Can Laser Make Melasma Worse? A Myth Check.